RE:Poppycock!I very strongly suspect you'll be playing the sad violin before too long and making a different excuse. Looking forward to your thoughts once they actually tell us the new submission date. End of Q3 and early Q4 have come and gone. All we have is more phase 2 optimization needed and in addition, collection of more >450 day data. Unclear if one or both needed after reading the NR for the 4th time. Maybe it met the obfuscation intent of the NR. No wonder the golf buddies are no longer buying dinner. It's upto the mom and pop types to cough up loose change. If getting fast track and frequent access creates this much turmoil in terms of new requirements added AFTER meeting previously announced criteria, wonder what the "regular" tracks go through with the FDA. Assuming of course, that this was FDA mandated and not a ploy to kick the can down the road... again. If this continues, TLT will end up being a seller of IP. Wonder what Sherri must be thinking now.